Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CC-97540 in Relapsed or Refractory Severe ANCA-Associated Vasculitis
NCT07388277Phase 2Active, not recruiting
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of BMS-986353 in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). Started Mar 2026; status: active, not recruiting.
02
Drugs
BMS-986353
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on NCT07388277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07388277.